**Jiangsu Hengagement Cryptocurrency and Blockchain Jiangsu Hengrui Pharmaceuticals Co Ltd has announced a partnership with GSK, a global pharmaceutical company, to license out several of its projects.

• The licensed projects include a potential treatment for chronic lung disease.
• The partnership is expected to bring in a significant amount of revenue for Hengrui.

Financial Details

• The total value of the deal is estimated to be around 120 billion US dollars.
• The partnership is expected to have a positive impact on Hengrui’s financial performance.

Market Reaction

• Jiangsu Hengrui Pharmaceuticals Co Ltd’s stock price has experienced a significant surge, rising by over 24% in a single day.
• The pharmaceutical sector as a whole has also seen a significant increase in value, with many companies in the sector experiencing a surge in their stock prices.

Key Statistics

• Stock price increase: 24%
• Total value of the deal: 120 billion US dollars